Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,011Revenue $M934Net Margin (%)15.3Z-Score1.6
Enterprise Value $M12,426EPS $2.2Operating Margin %29.1F-Score4
P/E(ttm))192Cash Flow Per Share $3.6Pre-tax Margin (%)22.7Higher ROA y-yN
Price/Book13.310-y EBITDA Growth Rate %0Quick Ratio1.4Cash flow > EarningsY
Price/Sales8.25-y EBITDA Growth Rate %0Current Ratio1.5Lower Leverage y-yN
Price/Cash Flow11.8y-y EBITDA Growth Rate %23.5ROA % (ttm)4.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)19.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M63.4ROI % (ttm)2.6Gross Margin Increase y-yN

Gurus Latest Trades with SLXP

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SLXPJoel Greenblatt 2014-06-30 Sold Out -0.48%$97.7 - $125.07
($110.33)
$ 160.846%Sold Out0
SLXPJoel Greenblatt 2014-03-31 Buy 0.48%$88.8 - $114.64
($101.95)
$ 160.858%New holding, 307445 sh.307,445
SLXPJoel Greenblatt 2013-09-30 Sold Out -0.36%$65.73 - $75.54
($68.97)
$ 160.8133%Sold Out0
SLXPJoel Greenblatt 2013-06-30 Buy 0.36%$47.72 - $66.83
($57.19)
$ 160.8181%New holding, 127495 sh.127,495
SLXPVanguard Health Care Fund 2013-03-31 Add0.08%$40.472 - $51.37
($47.96)
$ 160.8235%Add 22.44%2,147,945
SLXPJoel Greenblatt 2013-03-31 Sold Out -0.15%$40.472 - $51.37
($47.96)
$ 160.8235%Sold Out0
SLXPJoel Greenblatt 2012-12-31 Add0.06%$37.97 - $42.9
($40.82)
$ 160.8294%Add 75.81%63,399
SLXPJoel Greenblatt 2012-09-30 Buy 0.1%$41.92 - $55.65
($47.44)
$ 160.8239%New holding, 36061 sh.36,061
SLXPVanguard Health Care Fund 2011-09-30 Add0.09%$26.18 - $40.9
($33.07)
$ 160.8386%Add 55.43%1,554,300
SLXPJohn Paulson 2011-09-30 Sold Out -0.2056%$26.18 - $40.9
($33.07)
$ 160.8386%Sold Out0
SLXPJohn Paulson 2011-06-30 Add0.19%$34.69 - $40.57
($37.85)
$ 160.8325%Add 971.43%1,500,000
SLXPGeorge Soros 2011-06-30 Sold Out $34.69 - $40.57
($37.85)
$ 160.8325%Sold Out0
SLXPJohn Paulson 2011-03-31 Buy 0.01%$31.61 - $48.03
($38.86)
$ 160.8314%New holding, 140000 sh.140,000
SLXPGeorge Soros 2011-03-31 Reduce$31.61 - $48.03
($38.86)
$ 160.8314%Reduce -95.44%5,700
SLXPVanguard Health Care Fund 2010-12-31 Buy 0.22%$35.96 - $48.61
($41.76)
$ 160.8285%New holding, 850000 sh.850,000
SLXPGeorge Soros 2010-12-31 Reduce-0.1%$35.96 - $48.61
($41.76)
$ 160.8285%Reduce -54.55%125,000
SLXPGeorge Soros 2010-09-30 Buy 0.16%$37.59 - $44.64
($41.19)
$ 160.8290%New holding, 275000 sh.275,000
SLXPGeorge Soros 2008-06-30 Sold Out -0.01%$6.25 - $7.68
($7)
$ 160.82197%Sold Out0
SLXPGeorge Soros 2007-12-31 Sold Out -0.01%$9.01 - $12.73
($11.4)
$ 160.81310%Sold Out0
SLXPGeorge Soros 2007-09-30 Buy 0.01%$10.97 - $13.32
($12.2)
$ 160.81218%New holding, 25320 sh.25,320
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SLXP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SLXP Vanguard Health Care Fund 2014-06-301,824,5452.880.59-10.25%
SLXP Joel Greenblatt 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


SLXP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOGAN CAROLYN JPresident & CEO 2014-06-26Sell53,057$123.3827.65view
Scruggs Rick DExecutive Vice President 2014-05-16Sell900$105.6749.04view
D ALONZO THOMASDirector 2014-04-22Sell11,530$110.8942.02view
Scruggs Rick DExecutive Vice President 2014-03-04Sell1,319$110.6642.32view
CHAPPELL JOHN FDirector 2014-03-04Sell10,000$112.240.37view
D ALONZO THOMASDirector 2014-01-10Sell12,050$91.8371.5view
DERBYSHIRE ADAM CEVP Finance/CFO 2014-01-09Sell30,001$91.4872.16view
Forbes William PEVP Research&Devel & CDO 2014-01-08Sell8,000$90.0674.87view
Scruggs Rick DExecutive Vice President 2014-01-07Sell8,463$88.3178.34view
KEANE WILLIAM PDirector 2014-01-07Sell22,500$88.3178.34view

Press Releases about SLXP :

Quarterly/Annual Reports about SLXP:

News about SLXP:

Articles On GuruFocus.com
Steven Cohen Has a Track Record of Impressive Returns Jul 31 2014 
Joel Greenblatt's Gotham Capital Top 5 New Stocks May 16 2014 
Weekly CFO Sells Highlight: FII, SLXP, CCK, VCI, WDC, STMP Dec 31 2012 
Weekly Guru Bargains Highlights: HMSY, FB, TSU, SLXP, ANR Oct 29 2012 
Value Shop Nuveen Investments Reports Second Quarter Portfolio Aug 19 2011 
Hedge Fund Giant John Paulson Reports Q2 Portfolio Aug 15 2011 
Salix Pharmaceuticals Ltd. (SLXP) President & CEO Carolyn J Logan sells 14,000 Shares Sep 23 2010 
Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C Derbyshire sells 5,000 Shares Dec 11 2009 
Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C Derbyshire sells 5,000 Shares Dec 02 2009 
Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C Derbyshire sells 5,000 Shares Nov 30 2009 


More From Other Websites
[$$] Allergan, Seeking to Fend Off Hostile Bid, Approaches Salix Aug 20 2014
[video] Faber Report: WSJ says Allergan approaches Salix Aug 20 2014
Salix Pharmaceuticals (SLXP) Jumps: Stock Moves 15.5% Higher Aug 20 2014
Some ETFs Salivating for a Salix Takeover Aug 20 2014
Video: Allergan May Seek Salix Deal To Avoid Valeant Aug 19 2014
Nasdaq stocks posting largest percentage increases Aug 19 2014
Allergan approaches Salix to fight Valeant bid Aug 19 2014
Indexes Rally On Strong Housing Data, Retail Reports Aug 19 2014
SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 19 2014
Why Salix Pharmaceuticals (SLXP) Stock Is Soaring Today Aug 19 2014
Salix Climbs to High on Report of Approach From Allergan Aug 19 2014
Allergan seeks deal with Salix to fend off Valeant: WSJ Aug 19 2014
Allergan seeks deal with Salix to fend off Valeant - WSJ Aug 19 2014
Allergan seeks deal with Salix to fend off Valeant - WSJ Aug 19 2014
JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition' Aug 19 2014
Salix Announces Early Termination of HSR Waiting Period for Pending Transaction Aug 19 2014
7:01 am Salix Pharma Announces Early Termination of HSR Waiting Period for Pending Transaction Aug 19 2014
Salix Announces Early Termination of HSR Waiting Period for Pending Transaction Aug 19 2014
Near Entries: Cavium, Autohome, Skyworks And Facebook Aug 18 2014
SALIX PHARMACEUTICALS LTD Financials Aug 15 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide